Potential Biomarkers of Impending Schizophrenia Relapse: Exploratory Analysis of a Randomized, Double-Blind, Placebo-Controlled, Phase-3 Study of Paliperidone Palmitate 3-Month Formulation

被引：0
|
作者：
Gopal, Srihari [1 ]
Furey, Maura [1 ]
Hibar, Derrek [1 ]
Kolb, Hartmuth [1 ]
Saad, Ziad [1 ]
Savitz, Adam [1 ]
Triana-Baltzer, Gallen [1 ]
机构：
[1] Janssen Res & Dev LLC, Raritan, NJ USA
来源：
BIOLOGICAL PSYCHIATRY | 2017年 / 81卷 / 10期
关键词：
Biomarkers; Cytokines and Chemokines; Relapse; Schizophrenia;
D O I：
10.1016/j.biopsych.2017.02.322
中图分类号：
Q189 [神经科学];
学科分类号：
071006 ;
摘要：
307
引用
收藏
页码：S126 / S127
页数：2
相关论文
共 50 条
  • [1] Efficacy and Safety of Paliperidone Palmitate 3-month Formulation in Schizophrenia: a Randomized, Double-blind, Placebo-controlled Study
    Berwaerts, J.
    Liu, Y.
    Gopal, S.
    Nuamah, I.
    Xu, H.
    Savitz, A.
    Coppola, D.
    Schotte, A.
    Remmerie, B.
    Maruta, N.
    Hough, D.
    [J]. EUROPEAN PSYCHIATRY, 2015, 30
  • [2] EFFICACY AND SAFETY OF PALIPERIDONE PALMITATE 3 MONTH FORMULATION: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY
    Berwaerts, Joris
    Liu, Yanning
    Gopal, Srihari
    Nuamah, Isaac
    Xu, Haiyan
    Savitz, Adam
    Coppola, Danielle
    Schotte, Alain
    Remmerie, Bart
    Maruta, Nataliya
    Hough, David W.
    [J]. SCHIZOPHRENIA BULLETIN, 2015, 41 : S302 - S302
  • [3] Paliperidone Palmitate 3-month Versus 1-month Formulation In Patients With Schizophrenia: A Randomized, Double-blind, Noninferiority Study
    Savitz, Adam
    Xu, Haiyan
    Gopal, Srihari
    Nuamah, Isaac
    Ravenstijn, Paulien
    Janik, Adam
    Schotte, Alain
    Hough, David
    Fleischhacker, Wolfgang W.
    [J]. BIOLOGICAL PSYCHIATRY, 2016, 79 (09) : 354S - 354S
  • [4] Paliperidone Palmitate 3-month vs 1-month Formulation in Patients with Schizophrenia: A Randomized, Double-Blind, Noninferiority Study
    Fleischhacker, W.
    Savitz, Adam
    Xu, Haiyan
    Gopal, Srihari
    Nuamah, Isaac
    Ravenstijn, Paulien
    Janik, Adam
    Schotte, Alain
    Hough, David
    [J]. NEUROPSYCHOPHARMACOLOGY, 2015, 40 : S398 - S399
  • [5] Efficacy and Safety of Paliperidone Palmitate 3-Month Formulation for Patients with Schizophrenia: A Randomized, Multicenter, Double-Blind, Noninferiority Study
    Savitz, Adam J.
    Xu, Haiyan
    Gopal, Srihari
    Nuamah, Isaac
    Ravenstijn, Paulien
    Janik, Adam
    Schotte, Alain
    Hough, David
    Fleischhacker, Wolfgang W.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 (07):
  • [6] HEALTH RESOURCE USE AND COST ANALYSIS OF SCHIZOPHRENIA PATIENTS PARTICIPATING IN A RANDOMIZED, MULTICENTER, DOUBLE-BLIND, RELAPSE PREVENTION STUDY OF PALIPERIDONE PALMITATE 3-MONTH FORMULATION
    Benson, C.
    Chirila, C.
    Graham, J.
    Radder, C.
    Zheng, Q.
    Woodruff, K.
    [J]. VALUE IN HEALTH, 2015, 18 (03) : A119 - A119
  • [7] Health Resource Use and Cost of Schizophrenia Patients Participating in a Randomized, Multicenter, Double-Blind, Relapse-Prevention Study of Paliperidone Palmitate 3-Month Formulation
    Benson, Carmela
    Muser, Erik
    Chirila, Costel
    Graham, Jonathan
    Radder, Christina
    Woodruff, Kimberly
    [J]. BIOLOGICAL PSYCHIATRY, 2016, 79 (09) : 222S - 222S
  • [8] Efficacy and Safety of the 3-Month Formulation of Paliperidone Palmitate vs Placebo for Relapse Prevention of Schizophrenia A Randomized Clinical Trial
    Berwaerts, Joris
    Liu, Yanning
    Gopal, Srihari
    Nuamah, Isaac
    Xu, Haiyan
    Savitz, Adam
    Coppola, Danielle
    Schotte, Alain
    Remmerie, Bart
    Maruta, Nataliya
    Hough, David W.
    [J]. JAMA PSYCHIATRY, 2015, 72 (08) : 830 - 839
  • [9] Paliperidone palmitate maintenance treatment in delaying the time-to-relapse in patients with schizophrenia: A randomized, double-blind, placebo-controlled study
    Hough, David
    Gopal, Srihari
    Vijapurkar, Ujjwala
    Lim, Pilar
    Morozova, Margarita
    Eerdekens, Marielle
    [J]. SCHIZOPHRENIA RESEARCH, 2010, 116 (2-3) : 107 - 117
  • [10] Efficacy and Safety of Paliperidone Palmitate 6-Month versus Paliperidone Palmitate 3-Month Long-Acting Injectable in European Patients with Schizophrenia: A Post Hoc Analysis of a Global Phase-3 Double-Blind Randomized Non-Inferiority Study
    Giron-Hernandez, Cesar
    Han, Joong Hee
    Alberio, Roberta
    Singh, Arun
    Garcia-Portilla, Maria Paz
    Pompili, Maurizio
    Knight, R. Karl
    Richarz, Ute
    Gopal, Srihari
    Antunes, Jose
    [J]. NEUROPSYCHIATRIC DISEASE AND TREATMENT, 2023, 19 : 895 - 906
12345